{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:04:01Z","timestamp":1784311441252,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021260","name":"Legacy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021260","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fridolin Foundation"},{"name":"IntraBio Inc"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Levacetylleucine (Aqneursa\u2122), an acetylated derivative and pro-drug of L-leucine, is the only FDA-approved monotherapy for Niemann\u2013Pick disease type C (NPC). Its acetyl group enables transport via monocarboxylate transporters, supporting blood\u2013brain barrier penetration and efficient cellular uptake. Inside cells, levacetylleucine is metabolised by acylases, generating elevated levels of L-leucine that enhance mitochondrial bioenergetics and is thought to ameliorate lysosomal dysfunction indirectly. Here, we describe a direct effect of levacetylleucine on lysosomal regulation through modulation of TFEB, the master transcription factor for lysosomal and autophagy genes. Levacetylleucine rapidly alters TFEB translocation between the cytoplasm and the nucleus in a biphasic, homeostasis-restoring manner. In wild-type HeLa cells, levacetylleucine promotes TFEB activation and nuclear localisation. However, in NPC1 disease models, where we show that TFEB is over-activated and enriched in the nucleus due to lysosomal stress, levacetylleucine reduces nuclear TFEB and restores a more normal cytoplasmic-to-nuclear balance. These effects occur at clinically relevant concentrations associated with lysosomal storage reduction. The effects of the drug are stereospecific: while the L-enantiomer is active, the D-enantiomer and racemate show no effect, revealing the antagonistic properties of the D-enantiomer. This bidirectional normalisation of TFEB activity highlights a direct mechanism through which levacetylleucine modulates lysosomal and autophagic pathways in the HeLa cell model, giving mechanistic insight into its therapeutic potential in NPC, and also across diverse neurological and neurodevelopmental disorders.<\/jats:p>","DOI":"10.1371\/journal.pone.0353834","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:30:42Z","timestamp":1784309442000},"page":"e0353834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["N-acetyl-L-leucine normalizes Transcription Factor EB activity by stereospecific bidirectional modulation in a HeLa cell model of Niemann-Pick disease type C"],"prefix":"10.1371","volume":"21","author":[{"given":"Lianne C.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0150-9661","authenticated-orcid":true,"given":"Wim","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Braine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Churchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Strupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4132-7646","authenticated-orcid":true,"given":"Antony","family":"Galione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"12","key":"pone.0353834.ref001","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.clinthera.2024.10.011","article-title":"Aqneursa (levacetylleucine)","volume":"46","author":"P Beninger","year":"2024","journal-title":"Clin Ther"},{"issue":"11","key":"pone.0353834.ref002","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/d41573-024-00162-9","article-title":"FDA approves first two drugs for rare Niemann-Pick disease","volume":"23","author":"A Mullard","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0353834.ref003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.tips.2025.02.003","article-title":"Levacetylleucine (N-acetyl-l-leucine) for Niemann-Pick disease type C","author":"R van Gool","year":"2025","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"pone.0353834.ref004","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa2310151","article-title":"Trial of N-Acetyl-l-Leucine in niemann-pick disease type C","volume":"390","author":"T Bremova-Ertl","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0353834.ref005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213589","article-title":"Disease-modifying, neuroprotective effect of N-Acetyl-l-leucine in adult and pediatric patients with niemann-pick disease type C","volume":"105","author":"MC Patterson","year":"2025","journal-title":"Neurology"},{"issue":"1","key":"pone.0353834.ref006","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1038\/s41598-021-95255-5","article-title":"Acetylation turns leucine into a drug by membrane transporter switching","volume":"11","author":"GC Churchill","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0353834.ref007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/jcm9041050","article-title":"Beneficial effects of acetyl-DL-leucine (ADLL) in a mouse model of sandhoff disease","volume":"9","author":"E Kaya","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"pone.0353834.ref008","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa148","article-title":"Acetyl-leucine slows disease progression in lysosomal storage disorders","volume":"3","author":"E Kaya","year":"2020","journal-title":"Brain Commun"},{"issue":"5","key":"pone.0353834.ref009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/tra.12726","article-title":"Staying in touch with the endocytic network: The importance of contacts for cholesterol transport","volume":"21","author":"A Martello","year":"2020","journal-title":"Traffic"},{"issue":"1","key":"pone.0353834.ref010","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1038\/s41467-019-12152-2","article-title":"NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress","volume":"10","author":"D H\u00f6glinger","year":"2019","journal-title":"Nat Commun"},{"key":"pone.0353834.ref011","article-title":"N-Acetyl-l-Leucine (NALL) rescues inter-organelle communication in Niemann-Pick disease type-C patient cells","author":"S Kiraly","year":"2025","journal-title":"BioRxiv"},{"issue":"1","key":"pone.0353834.ref012","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1038\/s41598-021-88693-8","article-title":"N-Acetyl-L-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice","volume":"11","author":"N Hegdekar","year":"2021","journal-title":"Sci Rep"},{"issue":"776","key":"pone.0353834.ref013","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adl4616","article-title":"Myeloid cell-specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease","volume":"16","author":"L Dinkel","year":"2024","journal-title":"Sci Transl Med"},{"issue":"5","key":"pone.0353834.ref014","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMe2313791","article-title":"N-Acetyl-l-leucine and neurodegenerative disease","volume":"390","author":"CJ Tifft","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0353834.ref015","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1471-4159.2010.06976.x","article-title":"Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches","volume":"116","author":"AI Rosenbaum","year":"2011","journal-title":"J Neurochem"},{"issue":"1","key":"pone.0353834.ref016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"FM Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"pone.0353834.ref017","article-title":"Small-molecule activation of TFEB alleviates Niemann-Pick disease type C via promoting lysosomal exocytosis and biogenesis","volume":"13","author":"K Du","year":"2025","journal-title":"Elife"},{"issue":"13","key":"pone.0353834.ref018","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.146365","article-title":"TFEB at a glance","volume":"129","author":"G Napolitano","year":"2016","journal-title":"J Cell Sci"},{"issue":"11","key":"pone.0353834.ref019","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798804","article-title":"The complex relationship between TFEB transcription factor phosphorylation and subcellular localization","volume":"37","author":"R Puertollano","year":"2018","journal-title":"EMBO J"},{"key":"pone.0353834.ref020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2018.05.012","article-title":"TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities","volume":"122","author":"CJ Cortes","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"1","key":"pone.0353834.ref021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41420-024-01850-6","article-title":"From the regulatory mechanism of TFEB to its therapeutic implications","volume":"10","author":"H Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"pone.0353834.ref022","doi-asserted-by":"crossref","first-page":"105855","DOI":"10.1016\/j.nbd.2022.105855","article-title":"TFEB in Alzheimer\u2019s disease: From molecular mechanisms to therapeutic implications","volume":"173","author":"Z Gu","year":"2022","journal-title":"Neurobiol Dis"},{"key":"pone.0353834.ref023","doi-asserted-by":"crossref","first-page":"41408","DOI":"10.1038\/srep41408","article-title":"A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency","volume":"7","author":"AK Tharkeshwar","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0353834.ref024","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0021-9258(18)43087-6","article-title":"Biological acetylation of natural amino acids","volume":"164","author":"K Bloch","year":"1946","journal-title":"J Biol Chem"},{"issue":"3","key":"pone.0353834.ref025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0021-9258(17)30863-3","article-title":"The metabolism of acetylamino acids","volume":"169","author":"K BlocH","year":"1947","journal-title":"J Biol Chem"},{"issue":"5","key":"pone.0353834.ref026","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"C Settembre","year":"2012","journal-title":"EMBO J"},{"issue":"2","key":"pone.0353834.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229585","article-title":"Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance","volume":"15","author":"GC Churchill","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0353834.ref028","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0021-9258(18)55898-1","article-title":"Specificity of amino acid acylases","volume":"194","author":"SM BirnbauM","year":"1952","journal-title":"J Biol Chem"},{"key":"pone.0353834.ref029","article-title":"Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection","volume":"4","author":"F Lu","year":"2015","journal-title":"Elife"},{"issue":"3","key":"pone.0353834.ref030","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/15548627.2016.1271514","article-title":"Multistep regulation of TFEB by MTORC1","volume":"13","author":"S Vega-Rubin-de-Celis","year":"2017","journal-title":"Autophagy"},{"issue":"19","key":"pone.0353834.ref031","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","article-title":"Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways","volume":"20","author":"M Palmieri","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pone.0353834.ref032","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/cells11020258","article-title":"Tfeb-mediated transcriptional regulation of autophagy induces autosis during ischemia\/reperfusion in the heart","volume":"11","author":"J Nah","year":"2022","journal-title":"Cells"},{"issue":"2","key":"pone.0353834.ref033","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/MCB.23.2.665-676.2003","article-title":"Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor alpha-induced cell death","volume":"23","author":"K Ono","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"7","key":"pone.0353834.ref034","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/cdd.2009.214","article-title":"Lysosomal membrane permeabilization and cathepsin release is a Bax\/Bak-dependent, amplifying event of apoptosis in fibroblasts and monocytes","volume":"17","author":"C Oberle","year":"2010","journal-title":"Cell Death Differ"},{"issue":"5","key":"pone.0353834.ref035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-022-04906-6","article-title":"Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease","volume":"13","author":"A Li","year":"2022","journal-title":"Cell Death Dis"},{"issue":"15","key":"pone.0353834.ref036","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1111\/jcmm.15301","article-title":"Lysosomal dysfunction-induced autophagic stress in diabetic kidney disease","volume":"24","author":"HJ Zheng","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"pone.0353834.ref037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/BJ20140645","article-title":"Transition metals activate TFEB in overexpressing cells","volume":"470","author":"KA Pe\u00f1a","year":"2015","journal-title":"Biochem J"},{"key":"pone.0353834.ref038","doi-asserted-by":"crossref","first-page":"1538166","DOI":"10.3389\/fnagi.2025.1538166","article-title":"Serine-129 phosphorylated \u03b1-synuclein drives mitochondrial dysfunction and calcium dysregulation in Parkinson\u2019s disease model","volume":"17","author":"J Jiao","year":"2025","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"pone.0353834.ref039","doi-asserted-by":"crossref","DOI":"10.1172\/JCI196137","article-title":"N-acetyl-l-leucine lowers \u03b1-synuclein levels and improves synaptic function in Parkinson\u2019s disease models","volume":"136","author":"P Song","year":"2026","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0353834.ref040","doi-asserted-by":"crossref","first-page":"109103","DOI":"10.1016\/j.ymgme.2025.109103","article-title":"Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C disease","volume":"145","author":"H Shammas","year":"2025","journal-title":"Mol Genet Metab"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:30:49Z","timestamp":1784309449000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353834"}},"subtitle":[],"editor":[{"given":"David","family":"Chau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353834","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}